Bluejay Diagnostics, Inc.
BJDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $2 | $1 | $1 |
| - Cash | $3 | $4 | $3 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | -$2 | -$2 | -$3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$2 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.01 | -1.41 | -11.64 | -8.94 |
| % Growth | 28.4% | 87.9% | -30.2% | – |
| Operating Cash Flow | -$1 | -$2 | -$1 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$1 | -$2 | -$1 | -$2 |